Thomas Wex
- Gastroenterology top 0.5%
- Gastroesophageal reflux and treatments 25
- Surgery top 1%
- Helicobacter pylori-related gastroenterology studies 93
- Eosinophilic Esophagitis 34
- Esophageal Cancer Research and Treatment 9
- Immunology top 5%
- Galectins and Cancer Biology 26
- IL-33, ST2, and ILC Pathways 10
- Cancer Research top 5%
- Small Animals top 1%
- Veterinary medicine and infectious diseases 10
-
- Gastric Cancer Management and Outcomes 18
- Co-authors
- Peter MalfertheinerDoerthe KuesterArne KandulskiAlbert RoessnerJan BornscheinMichael SelgradAlexander LinkU Peitz
- Cited by
- GastroenterologySurgeryImmunology
- Journals
- Gastroenterology (12 papers)Helicobacter (9 papers)Alimentary Pharmacology & Therapeutics (7 papers)
- Partner nations
- GermanyUnited StatesLatvia
In The Last Decade
Thomas Wex
152 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 126
- Gastroenterology 631
- Surgery 2.0k
- Immunology 853
- Cancer Research 574
- Small Animals 251
Countries citing papers authored by Thomas Wex
This map shows the geographic impact of Thomas Wex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wex more than expected).
Fields of papers citing papers by Thomas Wex
This network shows the impact of papers produced by Thomas Wex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wex. The network helps show where Thomas Wex may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Wex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 21 | |
| 2 | 2016 | 12 | |
| 3 | 2015 | 26 | |
| 4 | 2014 | 3 | |
| 5 | 2014 | 15 | |
| 6 | 2013 | 19 | |
| 7 | 2013 | 57 | |
| 8 | Authors' response: antibodies to GP2, the major zymogen granule membrane glycoprotein, are specific for Crohn's disease and may reflect treatment response | 2011 | 14 |
| 9 | Helicobacter pylori related and non-related lesions in the stomach. | 2011 | 4 |
| 10 | 2009 | 52 | |
| 11 | 2008 | 21 | |
| 12 | 2008 | 13 | |
| 13 | 2008 | 72 | |
| 14 | 2008 | 6 | |
| 15 | 2007 | 29 | |
| 16 | 2006 | 14 | |
| 17 | 2004 | 19 | |
| 18 | 2003 | 30 | |
| 19 | 2001 | 68 | |
| 20 | 1998 | 5 |
About Thomas Wex
Thomas Wex is a scholar working on Gastroenterology, Surgery and Immunology, having authored 153 papers that have together received 3.7k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (93 papers), Eosinophilic Esophagitis (34 papers), Galectins and Cancer Biology (26 papers), Gastroesophageal reflux and treatments (25 papers), Gastric Cancer Management and Outcomes (18 papers), IL-33, ST2, and ILC Pathways (10 papers), Veterinary medicine and infectious diseases (10 papers) and Esophageal Cancer Research and Treatment (9 papers). The work is most often cited by research in Gastroenterology (631 citations), Surgery (2.0k citations) and Immunology (853 citations). Thomas Wex has collaborated with scholars based in Germany, United States and Latvia. Frequent co-authors include Peter Malfertheiner, Doerthe Kuester, Arne Kandulski, Albert Roessner, Jan Bornschein, Michael Selgrad, Alexander Link, U Peitz, Gerhard Treiber and Jochen Weigt. Their work appears in journals such as Gastroenterology, Helicobacter, Alimentary Pharmacology & Therapeutics, BMC Gastroenterology and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.